SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-049677
Filing Date
2022-08-19
Accepted
2022-08-19 16:01:24
Documents
15
Period of Report
2022-08-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea164601-8k_emmauslife.htm   iXBRL 8-K 31230
2 PROMISSORY NOTE DATED AUGUST 16, 2022 IN THE PRINCIPAL AMOUNT OF $1,668,751 IN F ea164601ex10-1_emmauslife.htm EX-10.1 12956
3 PROMISSORY NOTE DATED AUGUST 16, 2022 IN THE PRINCIPAL AMOUNT OF $250,000 IN FAV ea164601ex10-2_emmauslife.htm EX-10.2 12614
4 PROMISSORY NOTE DATED AUGUST 15, 2022 IN THE PRINCIPAL AMOUNT OF $50,000 IN FAVO ea164601ex10-3_emmauslife.htm EX-10.3 12139
  Complete submission text file 0001213900-22-049677.txt   249916

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE emma-20220815.xsd EX-101.SCH 2974
6 XBRL LABEL FILE emma-20220815_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE emma-20220815_pre.xml EX-101.PRE 22369
9 EXTRACTED XBRL INSTANCE DOCUMENT ea164601-8k_emmauslife_htm.xml XML 3291
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35527 | Film No.: 221180727
SIC: 2834 Pharmaceutical Preparations